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Formation of Prothrombin 
Converting Activity 
After measurement of the conversion of prothrombin 
to thrombin in a purified system, a model has been 
constructed for the kinetics of the formation of 
prothrombin converting activity. In the model phospho-
lipid provides a surface on to which coagulant factors 
bind. 
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IN blood coagulation prothrombin is converted to throm-bin as the result of the interaction of several blood coagula-
tion factors 1•2• One of the features of blood coagulation 
theory, which is still controversial, is the precise identity 
of the prothrombin converting activity. While most 
authors agree that conversion of prothrombin requires 
the presence of activated factor X (factor Xa), factor V, 
phospholipid and calcium ions, the form of their inter-
action is still in debate. Some authors suggest that the final prothrombin converting substance is a form of factor 
V modified by its interaction with factor Xa (ref. 3), while 
others hold the view that factor V facilitates the enzyme 
conversion of prothrombin to thrombin by factor Xa (ref. 4). The function of the phospholipid in this system 
seems to depend on its providing a suitable surface on 
which this reaction may take place, rather than to any 
specific chemical constitution4 • 
We describe here experiments performed with purified 
reagents, in which the kinetics of prothrombin activation 
have been investigated with a view to elucidating further 
the nature of the process. 
Bovine prothrombin was prepared and given by Dr K. 
Denson5• The preparation contained 10,000 NIH u/ml. 
of prothrombin, and less than 10 per cent of contaminating 
material that had neither coagulant nor inhibitory activity. 
Bovine factor V was prepared according to Esnouf and 
Jobin8 ; the stock solution contained 40,000 u/ml. and had 
,. 
no detectable contamination. Factor Xa was prepared 
by the conversion of factor X (ref. 7) by the coagulant 
protein from Russell's viper venom8, and then separating 
the venom protein from factor Xa by chromatography4 • 
Factor Xa was not contaminated with any other clotting 
factors. 
The phospholipid was a commercial preparation of 
mixed phospholipids, 'Inosithin'. Emulsions of this 
phospholipid were prepared as described by Jobin and 
Esnouf4 • 
The experiments were carried out as follows. Phospho-
lipid, factor Xa and factor V were added together to the 
final concentration desired in a medium containing 12 
mm.olar calcium chloride and 40 =olar tris-hydrochloric 
acid buffer, pH 7·5. The mixture thus obtained was called 
the "first incubation mixture". It was kept at 37° C 
during the "first incubation time". Except in the experi-
ments shown in Fig. 1 where it is plotted along the abscissa, 
this time w.as always 4-6 min. After this the first incuba-
tion mixture was put in an ice bath at 0° C which prevented 
appreciable decay of prothrombin converting activity for 
at least 30 min. 
To 1·8 ml. of this "first incubation mixture" 0·2 ml. of 
the prothrombin solution was added at zero time of the 
second incubation. The concentration of prothrombin 
in the second incubation was thus 1,000 NIH u/ml.; 
this concentration represents an excess of substrate for 
the prothrombin activator, and did not seem to be in-
hibitory. 
From the second incubation mixture O· l ml. portions 
were sub-sampled into O· l ml. of fibrinogen solution of 
100 mg/ml. (human fibrinogen Kabi). The clotting time 
of this mixture was measured in a water bath at 37° C. 
The clotting times thus obtained were converted into 
concentrations ofthrombin by comparison with the clotting 
times obtained by dilutions of a standard thrombin 
solution, in comparable conditions of pH, ionic strength, 
calcium ion concentration and temperature. 
The amount of thrombin thus found was plotted against 
the incubation time in the second incubation mixture, 
and from this graph the initial velocity of thrombin 
formation induced by the prothrombin activator was 
estimated. 
A representative experiment is shown in Fig. 1. In this 
experiment a mixture with high prothrombin converting 
activity was diluted 1 in 3 and 2 in 3, and thrombin 
generation has been followed in the original sample as 
well as in the dilutions. The two lower lines in the graph 
are drawn at 2/3 and 1/3 of the slope of the steepest line. 
It can be seen that: (a) the thrombin generation curve 
cannot be distinguished from a straight line in the initial 
phase; (b) the initial velocity of thrombin generation can 
be regarded as proportional to the amount of prothrombin 
2 
0 
15 
10 
5 
1 2 3 4 5 7 8 9 10 
Incubation time (min) 
Fig. 1. Thrombin generation in a mixture containing prothrombin and 
prothrombinase activity. (11-111) Thrombin generation in a mixture 
containing 20 u/ml. of factor V, 8 U/ml. of factor Xa, 4 y/ml. ofphospho-
lipid, 1,000 NIH U/ml. of prothrombin, 12 mmolar of calcium chloride, 
and 40 mmolar tris hydrochloric acid buffer, pH 7·5. (0-0) Thrombin 
generation in the same mixture immediately after a 2 in 3 dilut.ion with 
40 mmolar tris-hydrochloric acitl buffer, pH 7·5 containing 12 mmolar 
calcium chloride. (J..-A.) The same immediately after al in 3 dilution. 
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Fig. 2. Generation of prothrombinase activity in a mixture containing 
factor V, factor X. and phospholipid. The final concentrations were 
25 u/ml. of factor V, 10, 5, 2·5 or 1 u/ml. of factor Xa (as indicated), 
5 y/ml. of phospholipid, 12 mmolar calcium chloride, and 40 mmolar 
t,.is-hydrochloricacid buffer.pH 7·5. Theconcentrationofprothrombinase 
is expressed in arbitrary units, one unit being defined as the amount that 
causes a velocity of thrombin generation of 1 NIH U/10 min during the 
second incubation. 
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converting activity present in the incubation mixture; 
(c) prothrombin converting activity tends to be unstable 
with larger dilutions, which can be deduced from the 
gradually declining slope of the thrombin generation 
curve at a low level of prothrombin converting activity; 
and (d) no lag period in thrombin formation is observed. 
It thus appeared acceptable to use the initial velocity of 
the thrombin generation curve obtained in the second 
incubation mixture, as a measure of prothrombin con-
verting activity in the first incubation mixture. 
Fig. 2 shows a typical curve of the generation of pro-
thrombin converting activity in a first incubation mixture. 
After mixing the components there is a rapid rise of activity 
which very gradually falls off again. As will be seen below, 
the amount of prothrombin converting activity formed 
bears a relationship to the concentrations of factors V 
and Xa, and phospholipid. By varying the amounts of 
the reactants we have not been able to create conditions 
whereby the prothrombin converting activity rose slowly 
to a high value. If one of the clotting factors (X,. or V) 
was an enzyme which catalysed the conversion of the 
other to prothrombinase, then such a progressive increase 
in activity in certain conditions might be expected. 
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Fig. S. Relation between concentration of factor V and prothrombinase 
activity. The inverse of the concentration of factor V exPressed in u .is 
plotted against the inverse of the prothrombinase activity expressed in u. 
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At relatively large concentrations (causing a velocity of 
thrombin formation of "'20 NIH u of thrombin/ml./10 
min), the half-life time of the prothrombin converting 
activity was estimated to be about 55 min; the half-life 
time of the prothrombin converting activity generated in a 
thrombin generation test (that is, in a system using normal 
plasma) was estimated to be about 10 min in the same 
conditions. Thus the prothrombin converting activity 
appeared to be more stable in its purified form than it is 
in plasma. This again emphasizes the point that an 
inhibitor of prothrombin conversion is likely to be present 
in plasma•. 
Figs. 3, 4 and 5 show that a linear relationship between 
the reciprocal of the concentration of either of the re-
actants and the reciprocal of the final prothrombin convert-
ing activity is the simplest kind of relationship that can be 
deduced from these experiments. Essentially the same 
results were obtained when the amount of thrombin was 
estimated spectrophotometrically as n-benzoyl arginine 
methyl esterase activity. 
This relationship cannot be accounted for by the 
reaction scheme of the type 
v 
x .. 
I 
I 
+ 
·-------;.. Prothrombinase 
or by any of its modifications. It can, however, be ac-
counted for by a model based on the assumptions that: 
(a) there are a fixed number of factor Xa binding sites 
and a fixed number of factor V binding sites on each 
unit phospholipid micelle surface; (b) prothrombin con-
version occurs when a factor Xa molecule and a factor V 
molecule, bound to the phospholipid surface, are in a 
favourable position one to the other; (c) binding of 
one of the factors does not influence the binding charac-
teristics of the other one5• This model can be written in 
the following reaction formulae 
P+VoF-P"'V 
P + Xa oF- P"' Xa 
P "'V + Xa ~ Prothrombinase 
P"' Xa + V ~ Prothrombinase 
The word prothrombinase refers to the complex which 
converts prothrombin __ tp thrombin, . ... .... . . . ..
With these assumptions the following relationships 
will exist: (a) the concentration of prothrombinase is 
proportional to the number of bound factor Xa. molecules/ 
unit of phospholipid surface as well as to the amount of 
bound factor V molecules per unit of phospholipid surface; 
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Fig. 4. Relation between concentration of factor Xaand prothrombinase 
activity. The inverse of the concentration of factor x. expressed in u 
is plotted against the inverse of the prothrombinase activity expressed 
inu. 
• 
50 
10 
1 2 4 
1 
[P. Lip.] (11/ml.) 
Flg. 5 •. Relation between phosphollpid and J.>rothromblnase activity 
The mverse of the phospholipid aoncentxat1on expressed in y/ml. • 
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(b) the concentration of prothrombinase is proportional 
to the amount ofphospholipid surface. This is written in a 
formula 
p,...,x p,...,y K C = K. P. --p- . p = p . P ,..., X . P ~ V 
Where C is prothrombinase concentration; P is phospho-
lipid concentration; P ~ X is phospholipid bound factor Xa concentration; P,..., V is phospholipid bound factor V 
concentration, and K is a constant. With tho aid of 
elementary mathematics it can be shown 
k+1 
from P + X _ - P ,..., X ; k-i/k+i = K' 
I 1 !_ + K' 
that p,...,x = X + p X.P and 
k+, 
from P + V _ ' P ,..., V; k-.fk+2 = K" 
le-, 
1 I + ~ + K 8 that p ,..., V = V p V 
.P 
1 p 
So that 0 = k ( _!_ + ! + !£.) . (! + __!: + _K" ) X P X.P V P V.P 
In these equations P, X and V indicate the total con-
centrations of phospholipid, factor Xa and factor V, 
respectively. For the two protein factors this formula 
accounts for the relations found: 1/0 is linearly propor-
tional to l/V at fixed V and P concentrations and linearly proportional to l/V at fixed X and P concentrations. 
When the relationship between C and P is examined 
the formula is best written in the form 
b = p + ~ (X+K') (V+K")+(v+x+K'+K") X~K 
At small concentrations of phospholipid P will become 
1 
negligible compared with p (X+K') (V + K") and the 
formula will reduce to 
I 1 I G = p (X +IC) (V + K") + (V+X+K'+K 0 ) XVK 
which accounts for the relationship which we found. 
At large concentrations of phospholipid the formula 
will reduce to 
1 1 0 = p + (V + X + K' + K") VXK 
7 
which predicts the inhibiting effect of excess phospholipid 
that is often found. 
This inhibitory action of excess phospholipid is not seen 
in the experiments shown in Fig. 5, because the range of 
phospholipid tested does not include the pertinent con-
centrations. 
From these results it can be seen that near maximal 
velocity is often found at relatively small concentrations 
of the three reactants. This finding explains many of 
the reports in the literature, stating that further addition 
of one particular reactant did not increase the final 
yield of prothrombinase. The conclusion that this reactant 
may not therefore be a constituent of prothrombinase 
is apparently not justified. 
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